Luminesce Alliance

The establishment of Australia’s largest computational biology team, part of Luminesce Alliance Data Enabling Platform, will mean that more precisely targeted cancer treatments can help children like Jack.

How computational biology helps children like Jack

Spinal Muscular Atrophy (SMA) is the leading genetic cause of infant death in Australia. The Newborn Screening Pilot (NBS) pilot by the NSW Government through Luminesce Alliance, has since screened over 100,000 babies.

Newborn Screening for SMA

Holly has a rare disease with the symptoms of autism, cerebral palsy, Parkinson’s disease, epilepsy and seizures and anxiety disorder… all in one little girl. Luminesce Alliance gene therapy research is progressing towards helping Holly and others like her.

Learn more about Holly and how gene therapy research can help

Children’s Precision Medicine Research

Researchers

We work with researchers and clinicians to find answers for children living with cancers, rare genetic diseases and neurological disorders.

Families

Find out how precision medicine can help children with cancers, neurological disorders and rare diseases.

Collaboration

Our project teams work in a highly networked environment extending to collaboration with more than 50 organisations. For more information view the opportunities below and visit collaboration opportunties.

Our research is helping to find answers

See all research

Luminesce Alliance brings together world-leading paediatric precision medicine researchers and clinicians to help find answers for children living with cancers, rare genetic diseases and neurological disorders.

Psychosocial Enabling Platform

Health Systems Implementation and Economics

THINK Drug Discovery

Functional Genomics Research Pipeline

Translational Tumour Biology

Kids Advanced Therapeutics

Kids Link

Collaboration Opportunities

INFORM2 (INdividualized Therapy for Relapsed Malignancies in Childhood)

Advanced Clinical Data Analytics

News and events

See all news

Our impact for children's health

Luminesce Alliance is excited to share the latest 2023-2024 Impact Report, showcasing our collective efforts to advance children’s health. This publication highlights the significant strides we have made in accelerating research and improving care for children facing cancer, rare diseases, and neurological conditions. The report provides a succinct overview of the work of our lead

Luminesce Alliance project wins Highly Commended in Research Australia Awards - Digital and Health Innovation

Luminesce Alliance Conference 2024: inspiring insights from precision medicine experts

EPIC-CP Pilot to benefit all Australian children living with disabilities

Access our psychosocial and equity focused research support

Luminesce Alliance - Functional Genomics Research Pipeline

Access Functional Genomic subsidised support services

Luminesce Alliance - THINK Advanced Therapeutics Program

Access THINK Advanced Therapeutics Pipeline Program

ZERO precision medicine study provides some hope to families

Luminesce Alliance supported projects and investigators featured in Research Australia's INSPIRE

Our partners

Luminesce Alliance – Innovation for Children’s Health is a not-for-profit cooperative joint venture established with the support of the NSW Government to coordinate and integrate paediatric research.